MIM
OGN icon

MetLife Investment Management’s Organon & Co OGN Stock Holding History

MetLife Investment Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.8K Buy
4,271
+14
+0.3% +$167 ﹤0.01% 2833
2026
Q1 		$25.5K Buy
4,257
+7
+0.2% +$53 ﹤0.01% 2728
2025
Q4 		$30.5K Sell
4,250
-80
-2% -$632 ﹤0.01% 2761
2025
Q3 		$46.2K Buy
4,330
+4
+0.1% +$39 ﹤0.01% 2799
2025
Q2 		$41.9K Sell
4,326
-299
-6% -$3.08K ﹤0.01% 2692
2025
Q1 		$68.9K Buy
4,625
+106
+2% +$1.63K ﹤0.01% 2651
2024
Q4 		$67.4K Buy
4,519
+13
+0.3% +$212 ﹤0.01% 2711
2024
Q3 		$86.2K Sell
4,506
-102
-2% -$2.11K ﹤0.01% 2682
2024
Q2 		$95.4K Sell
4,608
-374
-8% -$7.43K ﹤0.01% 2630
2024
Q1 		$93.7K Buy
4,982
+12
+0.2% +$206 ﹤0.01% 2565
2023
Q4 		$71.7K Sell
4,970
-58,236
-92% -$792K ﹤0.01% 2732
2023
Q3 		$1.1M Sell
63,206
-1,534
-2% -$32K 0.01% 1181
2023
Q2 		$1.35M Sell
64,740
-893
-1% -$19.4K 0.01% 1109
2023
Q1 		$1.54M Sell
65,633
-788
-1% -$21.2K 0.01% 1010
2022
Q4 		$1.86M Sell
66,421
-1,077
-2% -$27.5K 0.01% 935
2022
Q3 		$1.58M Sell
67,498
-836
-1% -$25.2K 0.01% 980
2022
Q2 		$2.31M Sell
68,334
-653
-0.9% -$22.9K 0.02% 846
2022
Q1 		$2.41M Buy
68,987
+12,969
+23% +$444K 0.02% 923
2021
Q4 		$1.71M Sell
56,018
-1,241
-2% -$40.4K 0.01% 923
2021
Q3 		$1.88M Sell
57,259
-1,404
-2% -$44.9K 0.02% 884
2021
Q2 		$1.78M Buy
+58,663
New +$1.93M 0.02% 923

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

MetLife Investment Management's OGN Position: Q2 2026 in Review

MetLife Investment Management increased its Organon & Co (OGN) stake by 0.33% in Q2 2026, buying an estimated $167 and bringing the position to 4,271 shares worth $57.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2833.

MetLife Investment Management first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.41M in Q1 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • MetLife Investment Management held 4,271 shares of Organon & Co worth $57.8K as of Q2 2026.
  • MetLife Investment Management bought 14 Organon & Co shares in Q2 2026, an estimated $167.
  • Organon & Co made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2833 holding.
  • MetLife Investment Management first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • MetLife Investment Management's Organon & Co position peaked at $2.41M in Q1 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.